Incidence of Fragile X in 5,000 Consecutive Newborn Males

Genetic Testing

Volumn 7, Issue 4, 2003, Pages 339-343

  Rife M ^a,c   Badenas, C ^a   Mallolas, J ^a   Jimenez L ^a   Cervera, R ^a   Maya, A ^b   Glover, G ^d   Rivera, F ^a   Mila M ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b Institut de Bioquimica Clinica Barcelona   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; FRAGILE X SYNDROME; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEWBORN; NEWBORN SCREENING; SPAIN;

FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE FREQUENCY; HETEROZYGOTE; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; MUTATION; NEONATAL SCREENING; NERVE TISSUE PROTEINS; REFERENCE VALUES; RNA-BINDING PROTEINS; SPAIN; TRINUCLEOTIDE REPEATS;

EID: 1042301290     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703322783725     Document Type: Article

References (30)

1. ALLEN, K.M., GLEESON, J.G., BAGRODIA, S., PARTINGTON, M.W., MACMILLAN, J.C., CERIONE, R.A., MULLEY, J.C., and WALSH, C.A. (1998). PAK-3 mutation in nonsyndromic X-linked mental retardation. Nature Genet. 20, 25-30.
2. ARRIETA, I., CRIADO, B., MARTINEZ, B., TELEZ, M., NUÑEZ, T., PENAGARIKANO, O., ORTEGA, B., and LOSTAO, C.M. (1999). A survey of fragile X syndrome in a sample from Spanish Basque country. Ann. Genet. 42, 197-201.
3. AUDREZET, M.P., COSTES, B., GHANEM, N., FANEN, P., VERLINGUE, C., MORIN, J.F., MERCIER, B., GOOSSENS, M., and FÉREC, C. (1993). Screening for cystic fibrosis in dried blood spots of newborns. Mol. Cell Probes 76, 497-502.
4. BERESFORD, R.G., TATLIDIL, C., RIDDELL, D.C., WEELCH, J.P., LUDMAN, M.D., NEUMANN, P.E., and GREER, W.L. (2000). Absence of fragile X syndrome in Nova Scotia. J. Med. Genet. 37, 77-79.
5. CHIURAZZI, P., and NERI, J. (2000). Fragile X syndrome screening: A current opinion. Commun. Genet. 3, 38-40.
6. CRAWFORD, D.C., ACUÑA, J.M., and SHERMAN, S.L. (2001). FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet. Med. 3, 359-371.
7. DAWSON, A.J., CHODIRKER, B.N., and CHUDLEY, A.E. (1995). Frequency of FMR1 permutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol. Med. 56, 63-69.
8. DOMBROWSKI, C., LÉVESQUE, S., MOREL, M.L., ROUILLARD, P., MORGAN, K., and ROUSSEAU, F. (2002). Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum. Mol. Genet. 11, 371-378.
9. FALIK-ZACCAI, T.C., SHACHAK, E., YALON, M., LIS, Z., BOROCHOWITZ, Z., MACPHERSON, J.N., NELSON, D.L., and EICHELER, E.E. (1997). Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am. J. Hum. Genet. 60, 103-112.
10. FU, Y.H., KUHL, P.A., PIZUTTI, A., PIERETTI, M., SUTCLIFFE, J.S., RICHARDS, S., VERKERK, A.J.M.H., HOLDEN, J.A., FENWIK, R.G., WARREN, S.T., ZHANG, F., OOSTRA, B.A., CASKEY, C.T., and NELSON, D. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman Paradox. Cell 67, 1047-1058.
11. HOLDEN, J.J.A., CHALIFOUX, M., WING, M., JULIEN-INALSINGH, C., LAWSON, J.S., HIGGINS, J.V., SHERMAN, S., and WHITE, B.N. (1995). Distribution and frequency of FMR1 CGG repeat numbers in the general population. Dev. Brain Dysfunct. 8, 405-407.
12. JACOBS, P.A., BULLMAN, H., MACPHERSON, J., YOUINGS, S., ROONEY, V., WATSON, A., and DENNIS, N.R. (1993). Population studies of the fragile X: a molecular approach. J. Med. Genet. 30, 454-459.
13. KNIGHT, J., FLANNERY, A.V., HIRST, M.C., CAMPBELL, L., CHRISTODOULOU, S.R., PHELPS, S.R., POINTON, J., MIDDLETON-PRICE, H.R., BARNICOAT, A., and PEMBREY, M.E. (1993). Trinucleotide repeat amplification and hyper methylation of CpG island in FRAXE mental retardation. Cell 74, 127-134.
14. KUNST, C.B., ZERYLNICK, C., KARICKHOFF, L., EICHLER, E., BULLARD, J., CHALIFOUX, M., HOLDEN, J.J., TORRONI, A., NELSON, D.L., and WARREN, S.T. (1996). FMR1 in global populations. Am. J. Hum. Gernet. 58, 513-522.
15. MAZURCZAK, T., BOCIAN, E., MILEWSKI, M., OBERSZTYN, E., STANCZAK, H., BAL, J., SZAMOTULSKA, K., and KARWACKI, M.W. (1996). Frequency of Fragile X syndrome among institutionalized mentally retarded males in Poland. Am. J. Med. Genet. 64, 184-186.
16. MILÀ, M., KRUYER, H., GLOVER, G., SÁNCHEZ, A., CARBONELL, P., CASTELLVÍ-BEL, S., VOLPINI, V., ROSELL, J., GABARRÓN, J., LÓPEZ, I., VILLA, M., BALLESTA, F., and ESTIVILL, X. (1994). Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families. Hum. Genet. 94, 395-400.
17. MILA, M., SANCHEZ, A., BADENAS, C., BRUN, C., JIMÉNEZ, D., VILLA, M.P., CASTELLVÍ-BEL, S., and ESTIVILL, X. (1997). Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation. Hum. Genet. 100, 503-507.
18. MILLAN, J.M., MARTINEZ, F., CADROY, A., GANDIA, J., CASQUERO, M., BANEYTO, M., BADIA, L., and PRIETO, F. (1999). Screening of FMR1 mutations among the mentally retarded: prevalence of the fragile X syndrome in Spain. Clin. Genet. 56, 98-99.
19. OBERLÉ, I., TOUSSEAU, F., HEITZ, D., KRETZ, D., DEVYS, D., HANAVER, A., BOVE, J., BERTHEAS, M., and MANDEL, J.L. (1991). Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102.
20. PATSALIS, P.C., SISMANI, C., HETTINGER, J.A., BOUMBA, I., GEORGIOU, I., STYLIANIDOU, G., ANASTASIADOU, V., KOUKOULLI, R., PAGOULATOS, G., and SYRROU, M. (1999). Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation and stability. Am. J. Med. Genet. 84, 184-190.
21. PESSO, R., BERKENSTADT, M., CUCKLE, H., GAK, E., PELEG, L., FRYDMAN, M., and BARKAI, G. (2000). Screening for fragile X syndrome in women of reproductive age. Prenat. Diagn. 20, 611-614.
22. RIFÉ, M., MALLOLAS, J., BADENAS, C., TAZÓN, B., RODRÍGUEZ, MIGUÉLEZ, M., PAMPOLS, T., SANCHEZ, A., and MILA, M. (2002). Pilot study for the neonatal screening of Fragile X syndrome. Prenat. Diagn. 22, 459-462.
23. RYYNÄNEN, M., HEINONEN, S., MAKKONEN, M., KAJANOJA, E., MANNERMAA, A., and PERTTI, K. (1999). Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur. J. Hum. Genet. 7, 212-216.
24. SINCLAIR, A.H., BERTA, P., PALMER, M.S., HAWKINS, J.R., GRIFFITHS, B.L., SMITH, M.J., FOSTER, J.W., FRISCHAUF, A.M., LOVELL-BADGE, R., and GOODFELLOW, P.N. (1990). A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240-244.
25. SLANEY, S.F., WILKIE, A.O.M., HIRST, M.C., CHARLTON, R., McKINLEY, M., POINTON, J., CHRISTODOULOU, Z., HUSON, S.M., and DAVIES, K.E. (1995). DNA testing for fragile X syndrome in schools for learning difficulties. Arch. Dis. Child 72, 33-37.
26. TUNÇBILEK, E., ALIKASIFOGLU, M., AKTAS, D., DUMAN, F., YANIK, H., ANAR, B., OOSTRA, B., and WILLEMSEN, R. (2000). Screening for the fragile X syndrome among mentally retarded males by hair root analysis. Am. J. Med. Genet. 95, 105-107.
27. TURNER, G., ROBINSON, H., LAING, S., and PURVIS-SMITH, S. (1986). Preventive screening for the fragile X syndrome. N. Engl. J. Med. 315, 607-609.
28. TURNER, G., WEBB, T., WAKES, S., and ROBINSON, H. (1996). Prevalence of fragile X syndrome. Am. J. Med. Genet. 64, 196-197.
29. WEBB, T.P., BUNDEY, S., THAKE, A., and TODD, J. (1986). The frequency of the fragile X chromosome among schoolchildren in Coventry. J. Med. Genet. 23, 396-399.
30. YOUINGS, S.A., MURRAY, A., DENNIS, N., ENNIS, S., LEWIS, C., McKECHNIE, N., POUND, M., SHARROCK, A., and JACOBS, P. (2000). FRAXA and FRAXE: the results of a five year survey. J. Med. Genet. 37, 415-421.